Press release - 06/02/2008 CSS-Systemhaus Schlegel: Plant cultures with an electronic identity card A software developed by the Stuttgart-based Systemhaus Schegel covers all activities related to administering cultures it guarantees the foolproof production and propagation of plants and when printed out on a thermal printer incorporates all the necessary information on a barcode label.https://www.gesundheitsindustrie-bw.de/en/article/press-release/css-systemhaus-schlegel-plant-cultures-with-an-electronic-identity-card
Article - 05/02/2008 Protecting the liver from oxygen stress The Emmy Noether junior research group in the Department of Surgery at the University Hospital of Heidelberg is to be funded with 1.2 million over the next five years. The group will focus on how tissue damage in donor livers can be prevented. The group headed by Dr. Martin Schneider.https://www.gesundheitsindustrie-bw.de/en/article/news/protecting-the-liver-from-oxygen-stress
Article - 03/02/2008 Reversal of R&D expenditure According to estimates by the German Federal Minister of Research and Education Annette Schavan Germany is on the right path towards the objective of spending three per cent of the countrys gross domestic product on research and development RD by the year 2010.https://www.gesundheitsindustrie-bw.de/en/article/news/reversal-of-r-d-expenditure
Article - 02/02/2008 Mannheim: Excellence Centre of Dermatology The new University Clinic for Dermatology Venerology and Allergology building located on the Mannheim hospital campus has now been opened. The hospital directed by Prof. Dr. med. Sergij Goerdt treats approximately 2000 patients on an inpatient basis.https://www.gesundheitsindustrie-bw.de/en/article/news/mannheim-excellence-centre-of-dermatology
Press release - 01/02/2008 Dr. Victor Sourjik receives C.H.S. Award 2007 Victor Sourjik received the prize for his research in the field of cellular signalling and as support for his research project on the analysis of bacterial chemotaxis. The award comes with a purse of 100000 which the beneficiary can use to carry out research projects. https://www.gesundheitsindustrie-bw.de/en/article/press-release/dr-victor-sourjik-receives-c-h-s-award-2007
Press release - 01/02/2008 Venture capital: Life sciences/ biotechnology investments VC-facts has published the Life Sciences Venture Capital Yearbook for the first time 2007. It shows that the total volume of financing in the life sciences amounts to 438.65 million euros.https://www.gesundheitsindustrie-bw.de/en/article/press-release/venture-capital-life-sciences-biotechnology-investments
Article - 01/02/2008 Trends in the German biotechnology sector 2008 German biotech companies are optimistic about 2008. So says a survey conducted by the German Biotechnology Industry Association BIO Deutschland e.V. in cooperation with the biotech magazine transkript.https://www.gesundheitsindustrie-bw.de/en/article/news/trends-in-the-german-biotechnology-sector-2008
Dossier - 01/02/2008 Glycobiotechnology - sugar research is picking up speed Alongside DNA and proteins sugar structures play an important role in cellular transport and communication processes. They are also part of the molecular control and regulation machinery making them of particular interest to biotechnologists. The pharmaceutical industry as well as the food sector and material sciences have realised the potential of sugar structures.https://www.gesundheitsindustrie-bw.de/en/article/dossier/glycobiotechnology-sugar-research-is-picking-up-speed
Article - 30/01/2008 How cells communicate Prof. Valentin Wittmann professor in the Department of Chemistry at the University of Constance is investigating carbohydrates. At present his major area of interest is carbohydrate-RNA and carbohydrate-protein interactions where he is trying to understand the biological functions of complex sugar molecules glycans.https://www.gesundheitsindustrie-bw.de/en/article/news/how-cells-communicate
Article - 29/01/2008 Breakthrough for glycomics New databases and bioinformatic tools provide the field of glycomics with a solid basis for dynamic development in molecular biology and medicine. Willi von der Lieth a researcher from Heidelberg was an important pioneer of glyco-bioinformatics. His sudden death is a great loss for this new scientific field.https://www.gesundheitsindustrie-bw.de/en/article/news/breakthrough-for-glycomics
Press release - 28/01/2008 Funding programme "Innovative therapies" Proposals can be submitted up until 9th April 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/funding-programme-innovative-therapies
Article - 28/01/2008 Funding programme "Medical systems biology - MedSys" Proposals must be submitted prior to 7th May 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/funding-programme-medical-systems-biology-medsys
Press release - 28/01/2008 Europeans believe biodiversity loss is a problem For 93 of Europeans preserving biodiversity is a moral obligation affecting current generations as stewards of nature. European citizens are also aware that their well-being and quality of life depend on biodiversity.https://www.gesundheitsindustrie-bw.de/en/article/press-release/europeans-believe-biodiversity-loss-is-a-problem
Press release - 28/01/2008 Funding programme "Neurodegenerative diseases" The deadline for submitting proposals is 7th April 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/funding-programme-neurodegenerative-diseases
Article - 26/01/2008 New prosthetic methods All movements - each grip and step - have their origin in the brain. Carsten Mehring and his group at the Bernstein Centre for Computational Neuroscience and the Institute for Biology I at the University of Freiburg plan to use brain signals for the control of prostheses or for the operation of computers.https://www.gesundheitsindustrie-bw.de/en/article/news/new-prosthetic-methods
Article - 25/01/2008 Glycosylation pattern as potential target for intervention Tumours develop sophisticated strategies to escape the immune defence. One of these strategies is the modification of the cells sugar coat. Specific immune cell receptors bind to these sugars thereby preventing the tumour cell from being discovered by the immune system. Medics from the University of Tübingen are investigating the mechanisms involved and are looking for therapeutic targets. https://www.gesundheitsindustrie-bw.de/en/article/news/glycosylation-pattern-as-potential-target-for-intervention
Article - 25/01/2008 How do cells work? Glycoconjugate cell coat models provide new answers At the Max Planck Institute for Metal Research in Stuttgart researchers are developing model systems that imitate the sugar coats of living cells. They hope to gain new insights into the regulation of biological functions and develop the system into a platform for biosensoric applications.https://www.gesundheitsindustrie-bw.de/en/article/news/how-do-cells-work-glycoconjugate-cell-coat-models-provide-new-answers
Article - 25/01/2008 More than just 'empty' calories: polysaccharides in food Oligosaccharides and low-molecular polysaccharides are polymers made of different sugar units. Specialist companies such as Esslingen-based Anoxymer GmbH are focusing on plant sugar structures that have a therapeutic and preventive benefit.https://www.gesundheitsindustrie-bw.de/en/article/news/more-than-just-empty-calories-polysaccharides-in-food
Article - 21/01/2008 Research project "Applied Pathogenomics" The deadline for the submission of preproposals is 29th February 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-project-applied-pathogenomics
Press release - 21/01/2008 Micro-biolytics GmbH - Top spectroscopy technology for the pharmaceutical industry Micro-biolytics GmbH now based in the Esslingen-based Life Science Centre develops and produces microsystems solutions for bioanalytical issues. With the support of networks micro-biolytics is hoping to considerably expand its activities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/micro-biolytics-gmbh-top-spectroscopy-technology-for-the-pharmaceutical-industry
Press release - 21/01/2008 Optical technologies - biophotonics and life sciences The BMBF has announced the guidelines for the new SMU innovative Optical Technologies funding programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/optical-technologies-biophotonics-and-life-sciences
Article - 21/01/2008 Research alliance between French and German researchers Scientists from Ulm and Paris have joined forces to develop new medications against malignant brain tumours. The two-year research project will focus on developing betulinic acid which is found in abundance in birch bark into a cancer drug.https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-alliance-between-french-and-german-researchers
Article - 21/01/2008 EU strengthens innovation potential of electronic health services The EU hopes to tap innovative markets through a Lead Markets Initiative LMI in which electronic health services eHealth were identified as an important market.https://www.gesundheitsindustrie-bw.de/en/article/news/eu-strengthens-innovation-potential-of-electronic-health-services
Press release - 20/01/2008 Genetic causes and therapy of cardiac insufficiency Since 2001 the Medical University Hospital in Heidelberg has coordinated the Cardiovascular Network within the framework of the National Genome Research Network NGFN which also involves nine other big German university hospitals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/genetic-causes-and-therapy-of-cardiac-insufficiency
Press release - 20/01/2008 LifeCodexx AG - Clarity within the genetic data jungle Constance based GATC Biotech founds the subsidiary company LifeCodexx AG. LifeCodexx is the first web-based information service for the storage and utilisation of biological and medical data from the analysis of genetic codes and protein codes in the EU.https://www.gesundheitsindustrie-bw.de/en/article/press-release/lifecodexx-ag-clarity-within-the-genetic-data-jungle